Cancer cells have been recently shown to express high level of short 3 0 UTR isoforms that can escape miRNA-mediated regulation. We present here a computational procedure for systematically identifying shortened 3 0 UTRs by Affymetrix 3 0 microarrays. The advantage of this technology compared to more recent and promising ones such as exon arrays and RNA-Seq is that, giving the relatively small cost, already existing datasets in public databases include a considerably higher number of experiments. Moreover, the design of Affymetrix Gene Chips is well-suited for 3 0 UTR analysis of a large number of genes. Initially, Affymetrix individual probes are regrouped into customized probesets mapping specifically the CDS or the 3 0 UTR of the transcript, according to RefSeq annotation. Then, candidate 3 0 UTR shortening events are identified by statistical differential expression analysis of customized probesets in different biological conditions. The procedure has been applied to expression data from two ovarian adenocarcinoma datasets. Selected gene sets are significantly enriched for annotated splice variant genes as well as genes involved in estrogen dependent cancer mechanisms, confirming the validity of the proposed procedure.
Introduction
In eukaryotes, genes are regulated at many different levels to produce the appropriate set of proteins for specific cell types. In particular, two crucial events in this process are the production of an intermediate molecule, the messenger RNA (mRNA) transcript, and the translation of the mRNA into proteins. In the past, studies on gene regulation were focused mainly at the transcription level. The recent discovery of RNA silencing pathways and mRNA control mechanisms (e.g. processing, export, and turnover), by which cells can rapidly change gene expression patterns, has created a new interest in the field of post-transcriptional regulation.
In this paper we focus on a particular mechanism of post-transcriptional regulation, namely the alternative polyadenylation and 3 0 UTR formation. Depending on spatial or temporal condition, this mechanism allows a single gene to encode multiple mRNAs differing only in their 3 0 end. 1, 2 This is relevant from the point of view of post-transcriptional regulation because if the 3 0 UTR of an mRNA is shorter or missing, miRNAs and other regulatory molecules are not longer able to bind. Recently, different works have shown that the expression of substantial amounts of mRNA isoforms with shorter 3 0 UTRs is characteristic of cells in proliferating state, like immune system activated cells, 3 cancer cell lines 4 and pluripotent stem cells. 5 We propose a novel computational procedure to systematically identify the 3 0 UTR shortening events through the analysis of Affymetrix 3 0 expression arrays. The proposed procedure is designed to extract information about 3 0 UTR isoforms from microarray data across different conditions. The advantage of this technology compared with more recent and promising ones such as exon arrays and RNA-Seq is that already existing datasets in public databases include a considerably higher number of experiments. Moreover, the design of Affymetrix 3 0 arrays is well-suited for 3 0 UTR analysis of a large number of genes. The required input consists of the Affymetrix 3 0 expression array for the samples of interest and experimental factors i.e. tested conditions. As final result we obtain a set of genes expressing different 3 0 UTR isoforms across the analyzed conditions. Initially, Affymetrix single probes are reannotated and assigned to the coding region (CDS) or the 3 0 UTR of the transcript, according to NCBI RefSeq database (release 45). 6 Then we define for each RefSeq two distinct custom probesets, the first one including probes covering specifically the CDS and a second one including probes covering specifically the 3 0 UTR. For each RefSeq, we calculate the ratio between the two corresponding custom probesets and we evaluate how this ratio changes across the explored conditions by statistical differential analysis.
The entire procedure has been applied to investigate 3 0 UTR shortening events in ovarian adenocarcinoma, for which expression data of both cancer cell lines and patient samples were publicly available. 7, 8 Results pointed out two groups of genes with shortened 3 0 UTR expression correlating with cancer phenotype in the analyzed datasets. Both identified groups were further analyzed for functional annotation, revealing that they are highly enriched for alternative splicing variant genes as well as genes involved in relevant pathways for cancer disease.
This paper is organized as follows. After a short introduction to the biological aspects of the problem in Sec. 2, we describe the developed procedure to identify short 3 0 UTR isoforms from expression arrays in Sec. 3. This section also describes the application of the entire procedure to publicly available datasets of ovarian adenocarcinoma.
Background
DNA information stored in eukaryotic genes is translated into proteins through a series of complex processes, carefully controlled at each step by specific regulatory mechanisms. The cell provides fine regulatory systems to regulate gene expression both at transcriptional and post-transcriptional levels, using several cis-acting signals located in the DNA sequence. Once eukaryotic mRNA is transcribed, it usually contains not only the protein coding sequence, but also additional segments, which are transcribed but not translated, namely a flanking 5'UTR and a final 3 0 UTR. UTRs contain motifs that are essential to regulate post-transcriptional processes (e.g. mRNA processing, export, surveillance, silencing by microRNAs and turnover). At the end of every mRNA there is a signal indicating that the end of the mRNA is reached called the polyadenylation (poly(A)) site. In many genes, two or more poly(A) sites are found in the 3 0 UTR, so that different isoforms with different 3 0 UTR length can be expressed. This mechanism, called alternative polyadenylation (APA) is quite common in human mRNAs and it is subject to tissue and condition specificity.
1,2 Consequences of APA are particularly relevant from the point of view of post-transcriptional regulation because if the 3 0 UTR of a mRNA is shorter or missing, miRNAs and other regulatory proteins are not longer able to bind. The choice of using one poly(A) site over another can depend on the abundance of protein factors associated with the cleavage/polyadenylation machinery that influences the efficiency and specificity of this process. APA can also be regulated through interaction with other nuclear events such as splicing and transcription. It is likely also influenced by chromatin, including nucleosome positioning around the poly(A) site, DNA methylation, and histone modifications. Recently, a link was established between 3 0 UTR length and cellular proliferation, leading to the hypothesis of APA being correlated with proliferating state. Moreover, Mayr et al. report that cancer cell lines are prone to produce consistently shorter 3 0 UTR isoforms compared to non transformed cells. 4 Given the broad availability of microarray experiments for cancer-related datasets, we propose a computational procedure to systematically identify differentially expressed 3 0 UTR isoforms from Affymetrix 3 0 expression arrays. With this technology, the abundance of a given transcript is detected by a set of 25-base-long oligonucleotides (\probes") complementary to the target mRNA sequence. The signal from these probes is aggregated into a probeset. Most of the probes on Affymetrix 3 0 array are designed to match targets near the 3 0 end of genes, because the 3 0 UTR is often more distinctive among related genes in a paralog family and also the 3 0 end of transcripts are more heavily represented in the cRNAs coming from the initial poly-T primed reverse transcription step. For this reason, the design of Affymetrix 3 0 arrays is well suited to investigate 3 0 UTR expression.
Methods and Results

Procedure to identify alternative polyadenylation events
We developed a computational procedure (Fig. 1) to systematically identify APA events by Affymetrix 3 0 expression arrays. The proposed procedure includes four main steps: (i) reannotation of Affymetrix single probes to the CDS or the 3 0 UTR of the transcript according to NCBI RefSeq database (release 45); (ii) definition of custom probesets targetting specifically the CDS and the 3 0 UTR of each RefSeq; (iii) computing the expression ratio between CDS and 3 0 UTR custom probesets of each RefSeq in the different explored conditions; (iv) identifying candidate APA events by statistical differential analysis of ratio changes associated with the biological conditions. The first step is devoted to the reannotation of original Affymetrix probes according to our current knowledge of genome and transcriptome. Probe-level alignment information has been derived from a recently published database, PlandbAffy, 9 that contains alignments of probe sequences from five Affymetrix microarrays to the human genome. A relevant feature of this probe mapping database is that each probe is provided with a quality score according to different specificity conditions. Green probes (the best ones), that we used for our work, are required to map the genome without mismatches and uniquely. We crossed information about HG-U133 Plus 2.0 probe sequence alignments with transcript annotation from RefSeq release 45 to assign each probe to the CDS or the 3 0 UTR of transcripts. Then, two custom probesets for each RefSeq have been defined, the first one including probes covering specifically the CDS and a second one including probes covering specifically the 3 0 UTR. To define a custom probeset, we required at least four green quality probes covering the corresponding region. With this criteria, custom probesets for 26,275 different RefSeq have been defined. The following step is devoted to computing the expression ratio between CDS and 3 0 UTR custom probesets from the analayzed microarray data. We obtain single probe intensity measures background corrected and RMA-normalized using standard BioConductor libraries. 10 A filter has been applied to remove probes, giving an intensity signal below the background in all explored conditions. Then, probe intensity measures have been summarized by the median value in each custom probeset and the negative log-ratio of 3 0 UTR vs. CDS expression has been computed for each RefSeq in each sample. The 3 0 UTR:CDS log-ratio is expected to significantly correlate with different biological conditions in case the 3 0 UTR is subject to shortening. Some splice variation of the CDS portion could in principle affect the calculation of 3 0 UTR:CDS ratio. However, due to the preference for the 3 0 region of the transcript in the array design, such an event is limited to the CDS splicing occurring closed to the stop codon. We consider that in the majority of the cases, the 3 0 UTR:CDS ratio is mainly influenced by 3 0 UTR alternative processing rather than CDS splice variation.
In the last step, we evaluate log-ratio changes across the explored conditions by applying t-test to compare values between different groups. We assume that 3 0 UTR: CDS log-ratio values represent a set of replicate measurements for each RefSeq in both normal and cancer condition. For each RefSeq, the question we wish to address is whether the 3 0 UTR:CDS log-ratio is significantly different in the two conditions. After verifying the normality of the 3 0 UTR:CDS log-ratio distribution, we assess differential analysis using t-test. Microarray experiments measure several thousand genes simultaneously across different conditions. Since we performed t-test on each gene separately, the incidence of false positives is proportional to the number of tests. Once corrected t-test p-values for multiple testing error by BenjaminiÀHochberg method, we consider as candidate events of shortened 3 0 UTR the cases in which 3 0 UTR:CDS log-ratio is significantly different between the two compared conditions. The custom probesets annotation file and the perl script used for computing 3 0 UTR:CDS ratios are available on request.
Application to ovarian adenocarcinoma
As a case study, the entire procedure has been applied to investigate 3 0 UTR shortening events in ovarian adenocarcinoma, for which HG-U133 Plus 2.0 expression data of both cancer cell lines and patient samples were publicly available. 7, 8 The first analyzed dataset (GEO ID GSE14407), to which we refer in the folowing as OvCellLines dataset, includes expression data for 12 samples of ovarian surface epithelial cells (OSE) and 12 samples of ovarian cancer epithelial cells (CEPI). We ran our procedure to identify candidate APA events fixing the t-test p-value threshold to 0.05. We then selected such significant cases in which the negative log-ratio 3 0 UTR:CDS is higher in cancer cells than in normal ovarian cells, in order to extract events of 3 0 UTR short isoform expression associated to cancer phenotype. With this criteria, we selected 250 candidate genes potentially subject to 3 0 UTR shortening in ovarian cancer cells (listed in Table 1 ). We ran the same analysis on a second publicly available dataset including four samples from adenocarcinoma patients and six normal tissue samples, to which we refer as OvTissues dataset (GEO ID GSE15578). This dataset provided us with a second set of 70 candidate APA events (listed in Table 2 ).
Accurate annotation of RNA products is a critical aspect in our proposed procedure. However, 3 0 UTRs are still incompletely annotated in humans. We investigated the hypothesis that the obtained 3 0 UTR:CDS log-ratio values can depend on the distance between the CDS and the 3 0 UTR probesets. To check if the distance between 3 0 UTR and CDS probes has any effect on the 3 0 UTR:CDS log-ratio, we investigated the relationship between the 3 0 UTR:CDS log-ratio and the corresponding 3 0 UTR length for all RefSeq included in our analysis. First, we plotted the 3 0 UTR length distribution for all RefSeq (Fig. 2(a) ). Then, we checked the 3 0 UTR: CDS log-ratios obtained for the RefSeq whose length corresponds to the midpoint of each length interval in the histogram. The graph we obtained is reported in Fig. 2(b) . It shows that there is no correlation between the 3 0 UTR:CDS log-ratio values and the length of the corresponding annotated 3 0 UTR, excluding the hypothesis of 3 0 UTR length effect on 3 0 UTR:CDS log-ratios. In order to functionally characterize the selected gene sets obtained in ovarian adenocarcinoma study, we computed gene-annotation enrichment analysis using DAVID functional annotation tool. 11 By this tool suite, the enrichment of different Tables 3 and 4 show that both selected gene sets for OvCellLines and OvTissues datasets are significantly enriched for annotated splice variant genes. This result implies that the proposed procedure is able to identify existing transcript isoforms from the analysis of expression data. Moreover, both selected gene sets are enriched with terms related to molecular mechanisms of cancer such as DNA repair and chromosomal rearrangement as well as estrogen dependent cancer mechanisms such as urogenital system development and BRCA1/BRCA2 susceptibility. We crossed the two selected gene sets to find common genes extracted from both analysis. The intersection contains seven genes, which does not represent a highly significant overlap between the two sets (Pv = 0.07, Fisher's exact test). This poor overlap might be due to a remarkable biological difference between ovarian patient samples and their model cell line samples. Notably, the overlapping set includes WNT2B, which encodes for a factor implicated in the ovarian Wnt signaling pathway 12 and plays important role in carcinogenesis. WNT2B gene is also known to exist in multiple isoforms and to have five validated alternative polyadenylation sites. 13 Probe intensity profile for WNT2B gene is reported in Fig. 3 . In this plot, probe intensity profiles for OSE and CEPI groups overlaps almost perfectly in the CDS region (black labels on the x axis), while they diverge in the 3 0 UTR (red labels on the x axis).
Finally, we studied the cases in which 3 0 UTRs are shortened in normal samples with respect to cancer samples. To do this, we applied our computational procedure to identify cases of longer 3 0 UTR in cancer samples compared to the normal ones. Fig. 3 . Probe intensity profiles for WNT2B gene. Profiles for OSE and CEPI groups overlap in the CDS region (black labels on the x-axis), while they clearly diverge in the 3 0 UTR (red labels on the x-axis).
The analysis of OvCellLines ovarian adenocarcinoma dataset results in a list of 113 genes with potential 3 0 UTR shortening associated to normal phenotype. Consistently with recent observations reported in the literature, this type of event is less frequently observed compared with 3 0 UTR shortening associated to cancer phenotype (250 genes). GO analysis for the 113 genes with longer 3 0 UTRs in cancer samples has been performed. As results, we extracted some GO terms related to neuron activity and regulation of kinases (see Table 5 ). GO terms obtained in this analysis are less significantly enriched compared to the ones obtained for genes with 3 0 UTR shortening associated to cancer phenotype. 
Discussion
Recent works reporting a connection bewteen short 3 0 UTR isoform expression and cellular proliferation phenotype have created a new interest for the study of alternative polyadenylation. This study proposes a novel procedure to systematically identify candidate 3 0 UTR shortening events through the analysis of Affymetrix 3 0 expression arrays. In the near future, techniques for sequencing the mRNA (RNA-Seq) will enable the study of post-transcriptioanl regulatory mechanisms more deeply and accurately. Currently, 3 0 microarrays data are already available for a considerably higher number of experiments and they can be exploited to study 3 0 UTR expression issues. The proposed procedure, described here in detail, has been applied to investigate 3 0 UTR shortening events in ovarian adenocarcinoma, for which Affymetrix expression data of both cancer cell lines and patient samples were publicly available. The results of the analysis include gene sets significantly enriched for annotated splice variant genes as well as genes involved in estrogen-dependent cancer mechanisms, confirming the validity of the proposed procedure. We are planning to extend the proposed procedure to exon-level arrays.
